Prominent biochemist Dr David Kyle, whose research 15 years ago resulted in the inclusion of DHA Omega-3 fats in almost all infant formulas, claims discoveries about the baby microbiome will lead to the “biggest development in infant nutrition in years”. In line with this, Tate and Lyle have invested two million dollars into Dr Kyle’s company Evolve Biosystems, earning the University of California spin out a total of nine million dollars for its first funding round.
Past research projects in the field of the microbiome have demonstrated causal links between caesarean births, formula feeding and antibiotic use and the rise of non-communicable diseases in the west like obesity, food intolerance as well as various allergies and asthma. Dr Kyle hopes to address the shift by developing supplements for the baby nutrition market that restore the baby microbiome.
